DAVID WISEMAN: Open Payments
NPI 1306987920 · TARBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 25 payments from 7 companies in 2025. Trend: 2023 $127 · 2024 $376 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $162 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| GENZYME CORPORATION | 3 | $66 |
| Viatris Specialty LLC | 2 | $40 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Grifols USA, LLC | 1 | $31 |
Products named: TRELEGY ELLIPTA, DUPIXENT, AIRSUPRA, YUPELRI, LUMRYZ, Prolastin-C Liquid, NUCALA.
Industry payments across NC — which companies pay providers there.
